Načítá se...
Spasticity in multiple sclerosis and role of glatiramer acetate treatment
INTRODUCTION: Spasticity is one of the most disabling and difficult-to-treat symptoms shown by patients with multiple sclerosis, who often show a suboptimal and unsatisfactory response to classic treatment and new available nonpharmacological alternatives. Due to the progressive nature of this condi...
Uloženo v:
| Vydáno v: | Brain Behav |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4589813/ https://ncbi.nlm.nih.gov/pubmed/26445705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.367 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|